111 related articles for article (PubMed ID: 3994395)
1. Relative abilities of phosphagens with different thermodynamic or kinetic properties to help sustain ATP and total adenylate pools in heart during ischemia.
Turner DM; Walker JB
Arch Biochem Biophys; 1985 May; 238(2):642-51. PubMed ID: 3994395
[TBL] [Abstract][Full Text] [Related]
2. Enhanced ability of skeletal muscle containing cyclocreatine phosphate to sustain ATP levels during ischemia following beta-adrenergic stimulation.
Turner DM; Walker JB
J Biol Chem; 1987 May; 262(14):6605-9. PubMed ID: 3571272
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
Roberts JJ; Walker JB
Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
Griffiths GR; Walker JB
J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421
[TBL] [Abstract][Full Text] [Related]
5. Myocardial protection during ischemia by prior feeding with the creatine analog: cyclocreatine.
Jacobstein MD; Gerken TA; Bhat AM; Carlier PG
J Am Coll Cardiol; 1989 Jul; 14(1):246-51. PubMed ID: 2738267
[TBL] [Abstract][Full Text] [Related]
6. Differences in nucleotide compartmentation and energy state in isolated and in situ rat heart: assessment by 31P-NMR spectroscopy.
Williams JP; Headrick JP
Biochim Biophys Acta; 1996 Aug; 1276(1):71-9. PubMed ID: 8764892
[TBL] [Abstract][Full Text] [Related]
7. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
Osbakken M; Ito K; Zhang D; Ponomarenko I; Ivanics T; Jahngen EG; Cohn M
Cardiology; 1992; 80(3-4):184-95. PubMed ID: 1511465
[TBL] [Abstract][Full Text] [Related]
8. Critical role of phosphagens in the energy cascade of cutaneous ischemia and protective action of phosphocreatine analogues in skin flap survival.
Cuono CB; Marquetand R; Klein MB; Armitage I
Plast Reconstr Surg; 1998 May; 101(6):1597-603. PubMed ID: 9583491
[TBL] [Abstract][Full Text] [Related]
9. Higher homolog and N-ethyl analog of creatine as synthetic phosphagen precursors in brain, heart, and muscle, repressors of liver amidinotransferase, and substrates for creatine catabolic enzymes.
Roberts JJ; Walker JB
J Biol Chem; 1985 Nov; 260(25):13502-8. PubMed ID: 4055745
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells.
Martin KJ; Chen SF; Clark GM; Degen D; Wajima M; Von Hoff DD; Kaddurah-Daouk R
J Natl Cancer Inst; 1994 Apr; 86(8):608-13. PubMed ID: 8145276
[TBL] [Abstract][Full Text] [Related]
11. [Metabolism of exogenous phosphocreatine and 3-phosphono-2-imino-1-methyl-4-hydroxy-imidazoline in the perfused rat heart during ischemia].
Kupriianov VV; Shteĭnshneĭder AIa; Lakomkin VL; Zueva MIu; Kapel'ko VI
Biokhimiia; 1987 Mar; 52(3):437-45. PubMed ID: 3580413
[TBL] [Abstract][Full Text] [Related]
12. Utilization of the synthetic phosphagen cyclocreatine phosphate by a simple brain model during stimulation by neuroexcitatory amino acids.
Woznicki DT; Walker JB
J Neurochem; 1988 May; 50(5):1640-7. PubMed ID: 2896231
[TBL] [Abstract][Full Text] [Related]
13. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
14. Total ischemia III: Effect of inhibition of anaerobic glycolysis.
Jennings RB; Reimer KA; Steenbergen C; Schaper J
J Mol Cell Cardiol; 1989 Feb; 21 Suppl 1():37-54. PubMed ID: 2733029
[TBL] [Abstract][Full Text] [Related]
15. Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischemia or epinephrine.
Annesley TM; Walker JB
J Biol Chem; 1980 May; 255(9):3924-30. PubMed ID: 7372660
[No Abstract] [Full Text] [Related]
16. Creatine kinase kinetics, ATP turnover, and cardiac performance in hearts depleted of creatine with the substrate analogue beta-guanidinopropionic acid.
Shoubridge EA; Jeffry FM; Keogh JM; Radda GK; Seymour AM
Biochim Biophys Acta; 1985 Oct; 847(1):25-32. PubMed ID: 4052460
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclocreatine feeding on levels of amino acids in rat hearts before and after an ischemic episode.
Osbakken M; Zhang DN; Nelson D; Erecińska M
Am J Physiol; 1991 Dec; 261(6 Pt 2):H1919-26. PubMed ID: 1684269
[TBL] [Abstract][Full Text] [Related]
18. Effects of glycogen depletion on ischemic injury in isolated rat hearts: insights into preconditioning.
Schaefer S; Carr LJ; Prussel E; Ramasamy R
Am J Physiol; 1995 Mar; 268(3 Pt 2):H935-44. PubMed ID: 7900892
[TBL] [Abstract][Full Text] [Related]
19. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts.
Finegan BA; Lopaschuk GD; Gandhi M; Clanachan AS
Am J Physiol; 1995 Nov; 269(5 Pt 2):H1767-75. PubMed ID: 7503276
[TBL] [Abstract][Full Text] [Related]
20. The role of phosphocreatine and ATP in contraction of normal and ischemic heart.
Kupriyanov VV; Lakomkin VL; Steinschneider AYa ; Novikova NA; Severina MYu ; Kapelko VI; Saks VA
Biomed Biochim Acta; 1987; 46(8-9):S493-8. PubMed ID: 3435507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
